FDA Moves to Strengthen Drug Supply Chain with PreCheck Program

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur – © Artur – stock.adobe.com

FDA announced on Aug. 7, 2025 a new program to increase regulatory predictability and facilitate construction of drug manufacturing facilities in the United States, with the purpose of strengthening the country’s domestic drug supply chain. FDA PreCheck was created in response to an executive order directing the agency to streamline review of domestic manufacturing plants and eliminate unnecessary regulatory requirements.

According to FDA, more than half of pharmaceuticals distributed in…